Tuomas T Rissanen Selected Research

Sarcoidosis (Schaumann Disease)

1/2022	Incidence of Sudden Cardiac Death and Life-Threatening Arrhythmias in Clinically Manifest Cardiac Sarcoidosis With and Without Current Indications for an Implantable Cardioverter Defibrillator.
1/2018	Outcome of Cardiac Sarcoidosis Presenting With High-Grade Atrioventricular Block.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tuomas T Rissanen Research Topics

Disease

6	Myocardial Infarction 09/2023 - 11/2013
5	Coronary Artery Disease (Coronary Atherosclerosis) 02/2023 - 01/2019
5	Hemorrhage 01/2023 - 04/2017
5	Ischemia 04/2017 - 04/2002
3	Coronary Disease (Coronary Heart Disease) 11/2018 - 02/2009
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2019
2	Sarcoidosis (Schaumann Disease) 01/2022 - 01/2018
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020 - 11/2013
2	Acute Coronary Syndrome 01/2020 - 01/2019
2	Thrombosis (Thrombus) 01/2019 - 12/2016
2	Hypoxia (Hypoxemia) 05/2004 - 04/2002
2	Atherosclerosis 10/2003 - 11/2002
1	Pathologic Constriction (Stenosis) 11/2023
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2022
1	Sudden Death 01/2021
1	Death (Near-Death Experience) 01/2021
1	Atrial Flutter (Flutter, Atrial) 12/2019
1	Tachycardia (Tachyarrhythmias) 12/2019
1	Cardiac Arrhythmias (Arrythmia) 01/2018
1	Hemangioma (Angioma) 10/2014
1	Heart Failure 11/2013
1	Infarction (Infarctions) 11/2013
1	Coronary Occlusion 11/2013
1	Retinal Neovascularization 04/2009
1	Pathologic Neovascularization 04/2009
1	Inflammation (Inflammations) 05/2004
1	Hyperplasia 03/2004
1	Neointima 03/2004
1	Edema (Dropsy) 01/2004
1	Pericardial Effusion 01/2004
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2003
1	Atherosclerotic Plaque (Atheroma) 11/2002

Drug/Important Bio-Agent (IBA)

6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2004 - 04/2002
3	Paclitaxel (Taxol)FDA LinkGeneric 11/2023 - 01/2019
3	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 05/2004 - 04/2002
2	LipidsIBA 09/2023 - 01/2020
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 09/2023 - 08/2021
2	omega-Chloroacetophenone (Mace)IBA 01/2023 - 04/2017
2	MetalsIBA 01/2020 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 05/2004 - 11/2002
1	Lipoproteins (Lipoprotein)IBA 09/2023
1	Biomarkers (Surrogate Marker)IBA 09/2023
1	CholesterolIBA 09/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2023
1	Interleukin-6 (Interleukin 6)IBA 08/2021
1	LDL CholesterolIBA 01/2020
1	oxidized low density lipoproteinIBA 01/2020
1	AnticoagulantsIBA 04/2017
1	Polytetrafluoroethylene (Teflon)FDA Link 11/2013
1	Vascular Endothelial Growth Factor BIBA 04/2009
1	Therapeutic UsesIBA 03/2007
1	Vascular Endothelial Growth FactorsIBA 03/2007
1	A-Form DNA (A-DNA)IBA 05/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2004
1	Platelet-Derived Growth FactorIBA 03/2004
1	Vascular Endothelial Growth Factor CIBA 03/2004
1	LigandsIBA 03/2004
1	Vascular Endothelial Growth Factor DIBA 10/2003
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 10/2003
1	Fibroblast Growth Factor 4IBA 01/2003
1	MitogensIBA 04/2002

Therapy/Procedure

5	Percutaneous Coronary Intervention 02/2023 - 01/2019
5	Therapeutics 01/2018 - 05/2004
4	Stents 01/2020 - 11/2013
3	Surgical Amputation (Amputations) 05/2004 - 04/2002
2	Secondary Prevention 01/2020 - 11/2018
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2022
1	Heart Transplantation (Grafting, Heart) 01/2021
1	Drug-Eluting Stents 01/2020
1	Cardiac Resynchronization Therapy Devices 12/2019
1	Defibrillators (Defibrillator) 01/2018